Immunotherapy

Gut bacteria essential for conquering milk allergy

Gut bacteria and compounds in poop are connected to long-lasting relief in kids with milk allergies treated with oral therapy.

Chip detects lung cancer treatment efficacy from blood draw

Circulating tumor cells predict progression in stage III NSCLC patients.

Cutting-edge AI tool sharpens focus on precision pathology

Integrating spatial transcriptomics and histology for super-resolution tissue inference.

Scientists discovered a protein that controls breast cancer’s ability to resist immunotherapy

A better way to predict and improve patient responses.

Allergy medicine may treat lung cancer, suggests research

IL-4 signaling in bone marrow promotes tumor-friendly myelopoiesis.

New immunotherapy offers hope for autoimmune skin disorders

Molecular networks diverge to program distinct functions in CD8+ skin-resident memory T cells.

Beef and dairy nutrient boosts immune response to cancer

Trans-vaccenic acid reprograms CD8+ T Cells for anti-tumor immunity.

Promising phase II Results: New SCLC immunotherapy

Advancing care: Tarlatamab in previously treated SCLC.

Potent anti-leukemia approach: Making immunotherapy safe for AML

Eliminating the leukemia, sparing healthy cells.

Advancements in aggressive prostate cancer therapy

Enzalutamide improves recurrent prostate cancer prognosis.

Tiny protein therapy for peanut-allergic toddlers

Peanut allergy study in toddlers: Sublingual immunotherapy results.

Promising trial preserves bladders in advanced cancer

Gemcitabine, Cisplatin, and Nivolumab in bladder cancer: Phase 2 trial.

Recent Stories